Weill Cornell Medicine researchers report a whole-genome sequencing algorithm may identify more patients for PARP inhibitor cancer therapies than current commercial tests, according to a study in Communications Medicine.
The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.
Researchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
A decade-long study shows lower rates of provider-initiated reanalysis among Hispanic, Asian, and Black patients compared with White patients.
Read More
Multi-omics study reveals psychiatric comorbidities in bladder pain syndrome patients while demonstrating advantages in hematological malignancies and repeat expansion analysis.
Read More
SPRQ-Nx chemistry for Revio and Vega platforms is designed to reduce sequencing expenses by up to 40% while adding multiomic capabilities.
Read More
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read More
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Read More
A study of 1,000 newborns found that genomic testing could identify hundreds of additional childhood conditions using the same blood sample from a heel-prick test.
Read More
The optimized protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kit for clinical research and precision medicine applications.
Read More
Wasatch BioLabs expands service portfolio with pharmacogenomics panel, telomere sequencing, and mRNA vaccine quality control workflows.
Read More
New materials aim to help patients and providers understand emerging molecular diagnostic tools for hypertensive disorders of pregnancy.
Read More
BEACONS, a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in US newborn screening.
Read More
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
Read More
New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
Read More
The French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.
Read More
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read More
The collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.
Read More